Sweeper’s lung disease: a cross-sectional study of an overlooked illness among sweepers of Pakistan
Shaikh Khurshid Anwar, Naeem Mehmood, Nasir Nasim, Maryam Khurshid, Bilal Khurshid
Department of Pulmonary Medicine, Pakistan Institute of Medical Sciences (PIMS), Islamabad, Pakistan
Background: Sweepers are prone to develop chronic obstructive pulmonary disease even without tobacco smoking.
Purpose: To investigate roadside dust as a cause of air flow obstruction among sweepers, and the role of spirometry in its preclinical diagnosis.
Material and methods: One-hundred nonsmoking sweepers (aged 30–60 years) of both sexes sweeping on roads for 8–12 hours a day for the Capital Development Authority of Islamabad, Pakistan were used as study participants (Group A). One-hundred healthy nonsmokers (aged 30–60 years) in the same socioeconomic group and living in the same environment represented the nonsweeper group (Group B). After proper clinical evaluation and chest X-rays, spirometric evaluation was carried out in both groups. Comparisons were drawn between various spirometric parameters.
Results: Pulmonary function tests showed that the mean forced vital capacity was 78 ± 1.40 in the sweeper group (Group A) and 83 ± 0.86 in the nonsweeper group (Group B). Mean forced expiratory volume in 1 second was 66 ± 1.67 in Group A and 85 ± 0.85 in Group B (P < 0.05), a difference of 19%. The forced midexpiratory flow was 41% lower in Group A than in Group B (P < 0.0001). The pattern of pulmonary function obstruction was shown to be proportional to the duration of exposure to dust caused by sweeping.
Conclusion: Occupational exposure to dust leads to an obstructive pattern among sweepers. Spirometry is the simplest, noninvasive technique to detect preclinical disease.
Keywords: COPD, sweepers, dust, spirometry
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML]
Readers of this article also read:
Exacerbation-related impairment of quality of life and work productivity in severe and very severe chronic obstructive pulmonary disease
Solem CT, Sun SX, Sudharshan L, Macahilig C, Katyal M, Gao X
Published Date: 10 December 2013
Effect of high-dose N-acetylcysteine on airway geometry, inflammation, and oxidative stress in COPD patients
De Backer J, Vos W, Van Holsbeke C, Vinchurkar S, Claes R, Parizel PM, De Backer W
Published Date: 22 November 2013
de Miguel Díez J, Chancafe Morgan J, Jiménez García R
Published Date: 28 June 2013
Effect of a network system for providing proper inhalation technique by community pharmacists on clinical outcomes in COPD patients
Takemura M, Mitsui K, Ido M, Matsumoto M, Koyama M, Inoue D, Takamatsu K, Itotani R, Ishitoko M, Suzuki S, Aihara K, Sakuramoto M, Kagioka H, Fukui M
Published Date: 9 May 2013
Efficacy and safety of eco-friendly inhalers: focus on combination ipratropium bromide and albuterol in chronic obstructive pulmonary disease
Published Date: 30 April 2013
Exacerbations among chronic bronchitis patients treated with maintenance medications from a US managed care population: an administrative claims data analysis
AbuDagga A, Sun SX, Tan H, Solem CT
Published Date: 9 April 2013
Prevalence of renal and hepatobiliary disease, laboratory abnormalities, and potentially toxic medication exposures among persons with COPD
Mapel DW, Marton JP
Published Date: 15 March 2013
Chronic obstructive pulmonary disease as a cardiovascular risk factor: results of a case-control study (CONSISTE study)
Published Date: 21 February 2013
Improving the quality of life in patients with chronic obstructive pulmonary disease: focus on indacaterol
Published Date: 14 February 2013
Doyle C, Dunt D, Ames D, Selvarajah S
Published Date: 4 January 2013